Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News Feature
  • Published:

Fresh from the biologic pipeline—2009

Nature Biotechnology volume 28, pages 307–310 (2010)Cite this article

Subjects

Human antibodies take center stage, as they pile up in the list of approved biologics in 2009. Cormac Sheridan reports.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2: FDA new molecular entities and biologics license applications since 2004 according to therapeutic indication.

References

  1. http://www.landesbioscience.com/journals/mabs/about#background

  2. Anonymous. CDER New Molecular Entity (NME)/ New BLA Calendar Year Approvals As of December 31, 2009 (FDA CDER, Washington, DC, 2009). http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/DrugandBiologicApprovalReports/NMEDrugandNewBiologicApprovals/UCM091096.pdf

  3. Hughes, B. Nat. Rev. Drug Disc. 9, 89–92 (2010).

    Article  CAS  Google Scholar 

  4. Segal, B.M. et al. Lancet Neurol. 7, 796–804 (2008).

    Article  CAS  Google Scholar 

  5. Pappas, D.A. et al. Nat. Rev. Drug Disc. 8, 695–696 (2009).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dublin

    Cormac Sheridan

Authors
  1. Cormac Sheridan
    View author publications

    You can also search for this author in PubMed Google Scholar

Supplementary information

Supplementary Text and Figures

Supplementary Table 1 (PDF 85 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sheridan, C. Fresh from the biologic pipeline—2009. Nat Biotechnol 28, 307–310 (2010). https://doi.org/10.1038/nbt0410-307

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0410-307

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research